Invention Grant
- Patent Title: Monoclonal anti-CD95L antibody
-
Application No.: US15927255Application Date: 2018-03-21
-
Publication No.: US10428154B2Publication Date: 2019-10-01
- Inventor: Christian Gieffers , Oliver Hill , Meinolf Thiemann , Jaromir Sykora , Christian Merz , Tim Schnyder , Harald Fricke
- Applicant: Apogenix AG
- Applicant Address: DE Heidelberg
- Assignee: Apogenix AG
- Current Assignee: Apogenix AG
- Current Assignee Address: DE Heidelberg
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Priority: EP15186468 20150923
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.
Public/Granted literature
- US20180208664A1 ANTI-CD95L ANTIBODY Public/Granted day:2018-07-26
Information query
